89bio, Inc. (ETNB)
NASDAQ: ETNB · IEX Real-Time Price · USD
7.60
-0.16 (-2.06%)
At close: Jul 2, 2024, 4:00 PM
7.98
+0.38 (5.00%)
After-hours: Jul 2, 2024, 7:53 PM EDT
89bio Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for 89bio stock have an average target of 28.14, with a low estimate of 14 and a high estimate of 37. The average target predicts an increase of 270.26% from the current stock price of 7.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for 89bio stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 4 | 4 | 4 | 4 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +281.58% | Jul 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +281.58% | Jun 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +281.58% | Jun 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +281.58% | Jun 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +281.58% | May 17, 2024 |
Financial Forecast
Revenue This Year
1.09M
Revenue Next Year
2.55M
from 1.09M
Increased by 133.30%
EPS This Year
-2.39
from -2.00
EPS Next Year
-2.82
from -2.39
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.9M | 18.4M | 50.2M | 419.3M | 1.1B |
| Avg | 1.1M | 2.6M | 30.7M | 159.1M | 471.3M |
| Low | n/a | n/a | 7.4M | 17.2M | 192.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,581.2% | 1,868.2% | 1,267.4% | 573.3% |
| Avg | - | 133.3% | 1,102.4% | 418.8% | 196.3% |
| Low | - | - | 190.8% | -44.1% | 20.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.01 | -2.15 | -0.82 | -0.51 | 0.55 |
| Avg | -2.39 | -2.82 | -2.64 | -1.79 | -0.99 |
| Low | -2.86 | -3.33 | -3.42 | -2.21 | -1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.